by Jordana Choucair | Jan 26, 2023 | Life Sciences
Frank Yiannas, Food and Drug Administration (FDA) deputy commissioner for the Office of Food Policy and Response, is resigning less than two months after a report criticized the structure and culture of the FDA’s food program and recommended a major overhaul....
by Jordana Choucair | Jan 26, 2023 | M&A
Walgreens Boots Alliance Inc. is considering a sale of its pharmacy automation business, which could be valued at as much as $2 billion. According to people familiar with the matter, the company has engaged advisors for the sales process, which could start next month...
by Jordana Choucair | Jan 25, 2023 | Inequities and SDOH
The Robert Wood Johnson Foundation and the NYU Grossman School of Medicine launched a new dashboard that aims to help policymakers examine and eliminate disparities. The tool compiles 36 key measures of health (e.g., deaths from cardiovascular disease and breast...
by Jordana Choucair | Jan 25, 2023 | Payers
The Blue Cross Blue Shield Association (BCBSA) released a white paper outlining several policy priorities for the current Congress. The policies are organized under three main aims: Improve competition among health care providers, enhance consumer access to lower-cost...
by Jordana Choucair | Jan 25, 2023 | Public Health/Prevention
The Centers for Disease Control and Prevention (CDC) is making several changes to its organizational structure to improve the agency’s operations and efficiency. Under the new structure, CDC Director Dr. Rochelle Walensky will oversee several divisions more directly...
by Jordana Choucair | Jan 24, 2023 | Life Sciences
New documents show that the Food and Drug Administration (FDA) wants to make Covid-19 vaccination a regular, once-a-year shot that is updated to match current strains of the virus. The agency would recommend two annual boosters of the revised shot for people who are...
Recent Comments